menu

Day one – Thursday, September 7

  • 11:00 AM – 13:00 PM - Session: Personalized Medicine in Oncology
      Chairpersons: E. P. Diamandis (Canada) and A. Andriolo (Brazil)
      • 11:00 – E. P. Diamandis (Canada) - The concept of personalized Cancer Biomarkers
      • 11:30 – J. Kinkorová (Czech Rep) - Biobanks a Significant tool for Research and Patien’s Treatment
      • 12:00 – J. Trapé (Spain) - Tumor Markers in effusions
      • 12:30 – L. Chinen (Brazil) - Circulating Tumor Cells as a tool for Personalized Medicine
  • 13:00 PM - Lunch
  • 14:00 PM – 16:30 PM - Session: Breast Cancer Biomarkers - New Approaches
      Chairpersons: V. Barak (Israel) and P. Stieber (Germany)
      • 14:00 – P. Stieber (Germany) - Tumor Markers: State of the art in Breast Cancer diagnosis
      • 14:30 – M. J.Duffy (Ireland) - Tumor markers in breast tumor tissue - Role in determining prognosis and guiding treatment
      • 15:00 – A. Nicolini (Italy) - An individual reference limit for ‘early’ diagnosis of metastatic breast cancer during prolonged postoperative follow-up
      • 15:30 – K. Faulstich (Germany) - Do Patients Benefit From More Precise Determinations of Recommended Markers in Breast Cancer?
      • 16:00 – V. Barak (Israel) - HER-2/neu in the management of Breast Cancer patients
  • 16:30 PM - Coffee break
  • 16:50 PM – 17:50 PM - Satellite Symposium Sponsored by Siemens
    • Cancer Assessment, a complete portfolio to diagnostic, monitor and help treatment of Patients with Breast Cancer
      Chairpersons: A. Andriolo (Brazil)
      • 16:50 – R. Molina (Spain) - HER-2/neu in patients with cancer of different origin. Clinical applications in breast cancer in combination with CEA, and mucin biomarkers
      • 17:20 – C. S. Neto (Brazil) - Morfological, Immunohistochemistry and Molecular Aspects of Breast Cancer Her-2 Neu positive
  • 18:00 PM - Welcome words
    • Congress President - A. Andriolo
    • ISOBM President - R. Molina
    • SBPC presidente - Alex Galoro
  • 18:30 PM - KEY NOTE LECTURE
    • The Fraction of Cancer Attributable to Ways of Life, Infections, Occupation, and Environmental Agents in Brazil in 2020
      Gulnar Azevedo e Silva (Brazil)
  • 19:30 PM - Opening ceremony - Reception at the Rio Othon Hotel
  • 8:30 AM – 17:45 PM Rendezvous area
    • Registration
    • Information
    • Poster exposition

Day two – Friday, September 8

  • 8:30 AM – 10:10 AM - Session: Prostate Cancer - Updating the utility of PSA
      Chairpersons: J. C. Lima (Brazil) and M. J. Duffy (Ireland)
      • 8:30 – M. J. Duffy (Ireland) - PSA in Screening for Prostate Cancer: More Good than Harm or More Harm than Good?
      • 9:00 – X. Filella (Spain) - PSA in the early diagnosis of Prostate cancer: State of the art
      • 9:30 – R. Kucera (Czech Rep) - PHI and Prostate Cancer - optimal management
      • 10:00 – B. T. Helfand (USA) - A multiparametric approach including Prostate Health Index (PHI) to improve upon existing prostate cancer screening and biopsy recommendations.
  • 10:30 AM - Coffee break
  • 10:45 AM – 11:45 AM - Multiple Myeloma - From diagnosis therapy
      Chairpersons: G. Loureiro (Brazil) and N. M. Sumita (Brazil)
      • 10:45 – Roberto Magalhães (Brazil) - Diagnostic criteria and classification of multiple myeloma
      • 11:10 – G. Loureiro (Brazil) - Protein electrophoresis and immunofixation in the diagnosis and follow-up of multiple myeloma
      • 11:35 – A. Andriolo (Brazil) - The Importance of Free Light Chain Dosage in Multiple Myeloma
  • 12:00 PM - KEY NOTE LECTURE
    • Magnetic Resonance Molecular Imaging of Cancer using Targeted Core/Shell Nanoparticles
      B. Tomanek
  • 12:30 PM - Lunch
  • 14:00 PM – 16:05 PM - Session: Gastrointestinal Cancer - The role of Tumor Markers in Digestive Cancer
      Chairpersons: A. Andriolo (Brazil) and J. M. Augé (Spain)
      • 14:00 – N. M. Forones (Brazil) - Tumor markers in the monitoring of gastrointestinal cancer. (CEA, CA19-9, CA125, AFP)
      • 14:25 – A. Waitzberg (Brazil) - Molecular pathology update in colorrectal carcinomas
      • 14:50 – F. F. Melo (Brazil) - The hole of host’s genetic polymorphism in the determination of gastric disease severity
      • 15:15 – J. M. Augé (Spain) - Using Fecal Immunochemical Test (FIT) for hemoglobin in a quantitative way for the diagnosis of colorectal neoplasia
      • 15:40 – O. Fiala - (Czech Rep) - Predictive role of KRAS mutation type in patients with metastatic colorectal cancer treated with bevacizumab
  • 16:05 PM - Coffee break
  • 16:20 PM – 18:25 PM - Session: Liquid Biopsy - Circulating Nucleosomes
      Chairpersons: M. Nap (The Netherlands) and S. Holdenrieder (Gemany)
      • 16:20 – S. Holdenrieder (Germany) - Epigenetic modification of circulating.nucleosomes as a new field of cancer diagnostics
      • 16:45 – Ib Christensen (Denmark) - Histone modification markers in colorectal cancer
      • 17:10 – S. Uhlig (Germany) - Preanalytic considerations on nucleosomic markers
      • 17:35 – E. Heitzer (Austria) - Nucleosome positioning as cancer biomarker
      • 18:00 – T. F. Bartelli (Brazil) - Gastric washes: an alternative approach for liquid biopsy-based biomarker identification in gastric adenocarcinoma patients
  • 18:30 PM – 19:30 PM - The ISOBM ABBOTT AWARD Ceremony
    • Lecture: The new era of therapies and biomarkers for Melanoma
      Vivian Barak (Israel)
  • 19:30 PM – 20:30 PM - ISOBM General Assembly
  • 8:30 AM – 18:00 PM Rendezvous area
    • Registration
    • Information and Vendor Exhibition
    • Poster exposition

Day three – Saturday, September 9

  • 8:30 AM – 11:30 AM - Session: Liquid Biopsy - Circulating Nucleic Acids
      Chairpersons: E. Heitzer (Austria), M. Chechlinska (Poland)
      • 8:30 – S. Holdenrieder (Germany) - Nucleic acid diagnostics for Cancer detection
      • 8:55 – E. Heitzer (Austria) - Diagnostic workflows for liquid biopsy approaches
      • 9:20 – V. Haselmann (Germany) - EQA tests for cf-DNA testing in plasma
      • 9:45 – M. Chechlinska (Poland) - MicroRNAs in tumor microenvironment
      • 10:10 – M. Pesta (Czech Rep) - miRNA patterns in Colorectal Cancer
      • 10:25 – G.Torrezan (Brazil) - The challenge ctDNA as tumor biomarker
  • 10:50 AM - Coffee break
  • 11:15 AM – 12:30 PM - KEY NOTE LECTURE
    • Cancer Classification and Early Cancer Detection
      Ian Cree (UK)
  • 12:30 PM – 14:00 AM - Satellite Symposium on Prostate Cancer sponsored by Beckman Coulter, coordinated by Dr. Brian Helfand – PHI’s value in the early detection of Prostate cancer
  • 14:00 PM – 16:05 PM - Session: Lung Cancer
    • New Tumor Markers: Utility in diagnosis and therapy monitoring
      Chairpersons: S. Holdenrieder (Germany) and M. H. W. Faulhaber (Brazil)
      • 14:00 – S. Holdenrieder (Germany) - Tumor marker kinetics in therapy monitoring of lung cancer patients
      • 14:25 - R. Molina (Spain) - Tumor markers in Lung Cancer. A new step in the diagnosis of Lung Cancer?
      • 14:50 – G. Castro (Brazil) - Immunotherapy in lung cancer
      • 15:15 – D. Carraro (Brazil) - Precision Oncology for guiding and monitoring target therapy in Lung tumors
      • 15:40 – V. Capelozzi (Brazil) - Emerging Biomarkers for Lung Cancer Immune Therapy.
  • 16:05 PM - Coffee break
  • 16:30 PM – 18:10 PM - Session: Emerging Concepts - New era of oncology
      Chairpersons: V. Barak (Israel) and Ric. Moro (Canada)
      • 16:30 – V. Martins (Brazil) - The role of exosomes in tumor biology and as tumorbiomarcador
      • 16:55 – M. Amorim (Brazil) - Microbiome and Cancer
      • 17:20 – P. C. H. Li (Canada) - Cancer biomarker detection using microfluidic nanotechnology
      • 17:45 – S. Sell (USA) - Cancer Immunotherapy: Breakthrough or “déjà vu, all over again”
  • 18:20 PM – 19:30 PM - KEY NOTE LECTURE
    • 18:20 – Ric Moro (Canada) - Combination of RECAF with other markers improves Cancer diagnosis
    • 18:55 – Raf Moro (Canada) - RECAF potential for Cancer targeting
  • 8:30 AM – 18:00 PM Rendezvous area
    • Registration
    • Informationn
    • Poster exposition
  • 20:00 PM – 22:00 PM - Gala dinner

Day four – Sunday, September 10

  • 8:30 AM – 10:10 AM - Session: Paraneoplastic syndromes
    • Are tumor markers useful in the differential diagnosis of Paraneoplastic syndromes?
      Chairpersons: R. Molina (Spain) and T. Stigbrand (Sweden)
      • 8:30 – R. Molina (Spain) - Cost/efficiency of the Tumor Marker use in the differential diagnosis of paraneoplastic syndromes or in cancer of unknown origin.
      • 8:55 - X Bosch. (Spain) - Clinical usefulness of tumor biomarkers in the diagnosis of cancer and paraneoplastic syndromes in quick diagnosis units
      • 9:20 – J. Trape (Spain)- Tumor markers as a diagnostic tool in patients with wasting syndrome
      • 9.45 – J. Rios (Spain) - Multifactorial statistical approach for diagnosis and evolution in cancer. From blood to p-value to patients
  • 10:10 AM – 11:25 AM - Session: European Group on Tumor Markers (EGTM)
    • Update on Tumor Markers: New Developments
    • Chairpersons: : M. J. Duffy (Ireland) and V. Barak (Israel)
      • 10:10 – M. J. Duffy (Ireland) - Personalized Treatment for Cancer: How Biomarkers are Showing the Way.
      • 10:35 – R. Molina (Spain) - HE4 in Ovarian Cancer
      • 11:00 – V. Barak (Israel) - Tumor Markers significance for Head and Neck Cancers
  • 11:25 AM - Coffee break
  • 11:45 AM – 13:00PM - Session: Endocrine Tumors
    • Chairpersons: : R. Molina (Spain) and M. E. Mendes (Brazil)
      • 11:45 – J. Oriola (Spain) - Genetic of endocrine tumors.
      • 12:10 – J. M. Auge (Spain) - ProGRP as tumor marker in Medullary Thyroid carcinoma
      • 12:35 – K. Jazdzewski (Poland) - The whole population screening program for inherited cancer
  • 13:00 PM – 13:30 PM - Concluding remarks and Closing Ceremony
  • 13:30 PM – 14:30 PM - Lunch
  • 14:30 PM – 17:00 PM - ISOBM Executive Board Meeting

ADDITIONAL INFORMATION

The ISOBM BOARD Meeting will occur September 6, from 15:00 to 19:00 and September 7, from 8:00 to 11:00 at the Rio Othon Palace Hotel.

September 7, 16:50 – 17:50 - Satellite Symposium Sponsored by Siemens: Cancer Assessment, a complete portfolio to diagnostic, monitor and help treatment of Patients with Breast Cancer.

ABBOTT AWARD – Friday, September 8, 18:20 – 19:20 - Vivian Barak (Israel) – The new era of therapies and biomarkers for Melanoma

September 9, 12:30 – 14:00 - Satellite Symposium on Prostate Cancer sponsored by Beckman Coulter, coordinated by Dr. Brian Helfand - A multiparametric approach including Prostate Health Index (PHI) to improve upon existing prostate cancer screening and biopsy recommendations.